Suppr超能文献

医院为增加β受体阻滞剂的使用量都采取了哪些措施?

What are hospitals doing to increase beta-blocker use?

作者信息

Bradley Elizabeth H, Holmboe Eric S, Wang Yongfei, Herrin Jeph, Frederick Paul D, Mattera Jennifer A, Roumanis Sarah A, Radford Martha J, Krumholz Harlan M

机构信息

Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, USA.

出版信息

Jt Comm J Qual Saf. 2003 Aug;29(8):409-15. doi: 10.1016/s1549-3741(03)29049-3.

Abstract

BACKGROUND

Despite the many proposed methods for improving quality, little is known about which methods are being applied in practice across the United States or their perceived effectiveness.

METHODS

A descriptive, cross-sectional analysis of data from a telephone survey of quality improvement staff in 234 randomly selected hospitals participating in the National Registry of Myocardial Infarction was conducted to examine the prevalence and perceived effectiveness of various quality improvement interventions directed at increasing beta-blocker use after acute myocardial infarction.

RESULTS

The mean and median number of quality improvement interventions directed at beta-blocker use in the past 4 years was 5.0 per hospital. The most commonly reported effort was performance reporting about beta-blocker use (87.9%), although only 26.7% used physician-specific performance reporting. More than half the hospitals implemented clinical pathways (58.1%), standing orders (56.8%), or care coordinators (50.4%). Care coordinators (63.4%) and computer support systems (61.6%) were most frequently rated as "very effective." Clinical pathways (24.2%), counseling physicians who had poor performance (26.9%), and reminder forms (23.0%) were most frequently rated as not effective.

CONCLUSIONS

Substantial variation in the types of quality improvement efforts implemented to increase beta-blocker use and perceived effectiveness were evident.

摘要

背景

尽管提出了许多提高质量的方法,但对于美国各地实际应用的方法及其感知到的有效性知之甚少。

方法

对参与国家心肌梗死注册系统的234家随机选择医院的质量改进人员进行电话调查,对数据进行描述性横断面分析,以检查针对急性心肌梗死后增加β受体阻滞剂使用的各种质量改进干预措施的患病率和感知有效性。

结果

在过去4年中,每家医院针对β受体阻滞剂使用的质量改进干预措施的平均数和中位数为5.0。最常报告的工作是关于β受体阻滞剂使用的绩效报告(87.9%),尽管只有26.7%使用医生特定的绩效报告。超过一半的医院实施了临床路径(58.1%)、长期医嘱(56.8%)或护理协调员(50.4%)。护理协调员(63.4%)和计算机支持系统(61.6%)最常被评为“非常有效”。临床路径(24.2%)、对表现不佳的医生进行咨询(26.9%)和提醒表格(23.0%)最常被评为无效。

结论

在为增加β受体阻滞剂使用而实施的质量改进工作类型和感知有效性方面存在明显差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验